Please assess the completion status of the following clinical trial:

Trial Title: EMRI SureScan™ Clinical Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subject has, or is at risk of having, a heart beat that is too slow and his/her doctor has determined he/she needs a pacemaker.~* Subject available for follow-up at study center for length of study.~* Subject able and willing to undergo elective MRI scanning without sedation.~Exclusion Criteria:~* Subject has, or is at risk of having, a heart beat that is too fast and his/her doctor has determined he/she needs an implantable cardioverter defibrillator (ICD).~* Subject needs or will need another MRI-scan, other than those required by the study, during the required study follow-up period.~* Pregnant women, or women of child bearing potential who are not on a reliable form of birth control.~* Subject with exclusion criteria required by local law.~* Subject who intends to participate in another clinical study during this clinical study.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- MRI group (Type: ACTIVE_COMPARATOR): The MRI group underwent a one-hour MRI scan at the 9-12 weeks post-implant follow-up.
- Control group (Type: OTHER): The control group waited for one hour (no MRI) at the 9-12 weeks post-implant follow-up.

Based on this trial design, predict the completion outcome and termination type (if applicable).